WORKSHOP
“Medical & Bioprinting Advancements — Personalized Implants and Tissue Engineering”
We bring together leading academic scientists and researchers!
November 11th, 2026 1pm - 5pm
Scope of the event
Additive manufacturing (AM) is revolutionizing healthcare by enabling personalized medical implants, dental devices, prosthetics, and tissue engineering. Bioprinting—the 3D printing of living cells and biomaterials—is opening new frontiers in regenerative medicine, organ fabrication, and drug testing platforms.
This workshop provides a comprehensive overview of medical and bioprinting innovations, examining technological capabilities, regulatory frameworks, clinical applications, and commercialization pathways. Participants will explore the scientific, engineering, and ethical considerations of printing patient-specific implants, scaffolds, and tissues.
Academic speakers will present cutting-edge research in biomaterials, scaffold design, cell viability, and tissue maturation. Industry experts will demonstrate real-world deployment of 3D-printed implants, dental solutions, and surgical guides. Regulatory representatives will discuss approval pathways, standards for patient safety, and harmonization of international guidelines.
The objective of this workshop is to equip clinicians, engineers, researchers, investors, and policymakers with actionable knowledge about the opportunities, challenges, and strategic considerations for adopting additive and bioprinting technologies in medicine.
Extended Key Takeaways & Outputs
- Comparative overview of personalized implants, dental devices, and tissue scaffolds
- Technical guidance on materials, printing processes, and biocompatibility
- Insights into regulatory approval, certification, and clinical trials
- Strategic recommendations for scaling medical and bioprinting applications
- Ethical and societal considerations of bioprinting living tissues
- Investor-oriented evaluation of commercialization potential and risks
Agenda & Speakers
13:00–13:05 — Introduction & Workshop Objectives
Organizer
- Overview of additive and bioprinting applications in healthcare
- Importance of patient-specific design, safety, and regulatory compliance
- Workshop objectives: clarity, comparability, and strategic guidance
- Expected outcomes for clinical, research, and industrial stakeholders
13:05–13:35 — Additive Manufacturing in Medical Devices
Speaker (Academia): N.N.
- 3D-printed implants, prosthetics, and surgical guides
- Material selection: metals, polymers, and ceramics
- Design optimization for patient-specific anatomical fit
- Lifecycle, cost, and manufacturing scalability considerations
13:35–14:05 — Dental & Orthopedic Bioprinting
Speaker (Academia):
N.N.
- 3D printing for dental crowns, orthodontic devices, and maxillofacial implants
- Hydrogel scaffolds and biocompatible resins
- Tissue integration and long-term performance
- Clinical case studies and outcomes
14:05–14:35 — Bioprinting Living Tissues: From Scaffold to Organ
Speaker (Academia):
N.N.
- Principles of bioprinting: cells, biomaterials, and growth factors
- Scaffold design, vascularization, and maturation of tissues
- Translational research for organ-on-chip and regenerative medicine
- Challenges in scale-up, reproducibility, and standardization
14:35–14:45 — Break
14:45–15:15 — Industrial Deployment & Commercialization of Medical 3D Printing
Speaker (Industry):
N.N.
- Manufacturing personalized implants at scale
- Quality control, regulatory compliance, and post-market surveillance
- Case studies of hospital and commercial adoption
- Economic and operational considerations
15:15–15:45 — Regulatory Pathways & Standards in Bioprinting
Speaker (Policy):
N.N.
- FDA approval processes for 3D-printed medical devices
- Bioprinting-specific standards and clinical validation
- Patient safety, risk management, and reporting frameworks
- International harmonization of regulations and guidelines
15:45–16:15 — Ethical, Societal & Commercial Considerations
Speaker (Policy/Academia):
N.N.
- Ethical implications of printing human tissues and organs
- Intellectual property and commercialization challenges
- Patient consent, data privacy, and societal acceptance
- Balancing innovation with safety and ethics
16:15–16:55 — Panel Discussion & Strategic Alignment
All Speakers + Moderator
- Future of personalized medicine with additive manufacturing
- Scaling bioprinting from lab to clinic
- Prioritizing research, investment, and clinical adoption
- Strategic recommendations for global deployment and regulation
Concluding remarks
Registration
Deadlines:
Early-Bird: until July 15th, 2026
Registration : until September 5th, 2026
The registration takes place online by filling out the form.
The registration and access to the virtual room for workshop is effective only if the fees payment has been confirmed.
Please note that INVIRTA MEMBERS can purchase all our workshops and services with 10% discount . If you desire to get more information on our membership please press here .
Prices* :
Industry: 150 € (early bird**: 125 €)
Academy: 125 € (early bird**: 100 €)
Students***: 90 € (early bird**: 75 €)
* Note that prices are subject to VAT (for European countries, except Germany, provide the VAT number of your organisation to be within the VAT reverse framework payment).
** Until November 15th, 2020
*** Copy of the registration certificate (Ph.D, undergraduates)
Special price offers for Workshop packages
Our Workshop packages are valid for any workshops offered by our academy and can be used anytime. If you want to use one of our packages press here.
